These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8396491)

  • 1. Interference with the cortisol axis by the microtubule antagonist, CPH82.
    Dahlqvist SR; Olsson T
    Br J Rheumatol; 1993 Sep; 32(9):804-6. PubMed ID: 8396491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of naproxen and sulphasalazine or methotrexate on hypothalamic-pituitary-adrenal axis activity in patients with rheumatoid arthritis.
    Eijsbouts AM; Kempers MJ; van den Hoogen FH; Laan RF; Hermus AR; Ross HA; Sweep FC; van de Putte LB
    Clin Exp Rheumatol; 2011; 29(1):35-42. PubMed ID: 21345290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic-pituitary-adrenal-glucocorticoid axis function in rheumatoid arthritis.
    Masi AT; Chrousos GP
    J Rheumatol; 1996 Apr; 23(4):577-81. PubMed ID: 8730107
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucocorticoid-like anti-inflammatory versus immunosuppressive effects of CPH 82 as a single drug therapy of moderately active rheumatoid arthritis patients.
    Masi AT; Chatterton RT
    Scand J Rheumatol; 2000; 29(2):85-8. PubMed ID: 10777120
    [No Abstract]   [Full Text] [Related]  

  • 5. Abnormal hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis. Effects of nonsteroidal antiinflammatory drugs and water immersion.
    Hall J; Morand EF; Medbak S; Zaman M; Perry L; Goulding NJ; Maddison PJ; O'Hare JP
    Arthritis Rheum; 1994 Aug; 37(8):1132-7. PubMed ID: 8053951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems.
    Härle P; Straub RH; Wiest R; Mayer A; Schölmerich J; Atzeni F; Carrabba M; Cutolo M; Sarzi-Puttini P
    Ann Rheum Dis; 2006 Jan; 65(1):51-6. PubMed ID: 15941834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
    Straub RH; Pongratz G; Schölmerich J; Kees F; Schaible TF; Antoni C; Kalden JR; Lorenz HM
    Arthritis Rheum; 2003 Jun; 48(6):1504-12. PubMed ID: 12794817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroid effect of CPH-82.
    Magnusson S
    Scand J Rheumatol; 1993; 22(3):136-7. PubMed ID: 8391161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of progestin administration on the hypothalamic-pituitary-adrenal axis and glucose homeostasis in dogs.
    Selman PJ; Mol JA; Rutteman GR; van Garderen E; van den Ingh TS; Rijnberk A
    J Reprod Fertil Suppl; 1997; 51():345-54. PubMed ID: 9404305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamo-pituitary-adrenal axis and growth hormone axis in patients with rheumatoid arthritis.
    Demir H; Keleştimur F; Tunç M; Kirnap M; Ozügül Y
    Scand J Rheumatol; 1999; 28(1):41-6. PubMed ID: 10092164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic Cushing's syndrome combined with cortisol suppressible, dexamethasone non-suppressible ACTH secretion: a new variant of Cushing's syndrome.
    Schweikert HU; Fehm HL; Fahlbusch R; Martin R; Kolloch R; Higuchi M; Krück F
    Acta Endocrinol (Copenh); 1985 Nov; 110(3):289-95. PubMed ID: 3000118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis.
    Straub RH; Pongratz G; Cutolo M; Wijbrandts CA; Baeten D; Fleck M; Atzeni F; Grunke M; Kalden JR; Schölmerich J; Lorenz HM; Tak PP; Sarzi-Puttini P
    Arthritis Rheum; 2008 Apr; 58(4):976-84. PubMed ID: 18383357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimentally challenged reactivity of the hypothalamic pituitary adrenal axis in patients with recently diagnosed rheumatoid arthritis.
    Dekkers JC; Geenen R; Godaert GL; Glaudemans KA; Lafeber FP; van Doornen LJ; Bijlsma JW
    J Rheumatol; 2001 Jul; 28(7):1496-504. PubMed ID: 11469453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamo-pituitary-adrenal axis dysregulation in patients with rheumatoid arthritis after the dexamethasone/corticotrophin releasing factor test.
    Harbuz MS; Korendowych E; Jessop DS; Crown AL; Li pdfan SL; Kirwan JR
    J Endocrinol; 2003 Jul; 178(1):55-60. PubMed ID: 12844336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infusion of epinephrine decreases serum levels of cortisol and 17-hydroxyprogesterone in patients with rheumatoid arthritis.
    Straub RH; Kittner JM; Heijnen C; Schedlowski M; Schmidt RE; Jacobs R
    J Rheumatol; 2002 Aug; 29(8):1659-64. PubMed ID: 12180725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of aminoglutethimide on hypothalamic-pituitary-adrenal functions.
    Pan CY; Luo GC; Li JY; Wang YZ; Lu SZ; Ma SQ; Guo AY
    Chin Med J (Engl); 1989 Nov; 102(11):890-4. PubMed ID: 2561555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: a controlled study using insulin hypoglycemia stress test and prolactin stimulation.
    Gutiérrez MA; García ME; Rodriguez JA; Mardonez G; Jacobelli S; Rivero S
    J Rheumatol; 1999 Feb; 26(2):277-81. PubMed ID: 9972958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine effects of the podophyllotoxine derivative drug CPH 82 (Reumacon) in patients with rheumatoid arthritis.
    Carlström K; Hedin PJ; Jönsson L; Lerndal T; Lien J; Weitoft T; Axelson M
    Scand J Rheumatol; 2000; 29(2):89-94. PubMed ID: 10777121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.